Alnylam Pharmaceuticals , Inc. (NASDAQ:ALNY), a leader in RNA interference (RNAi) therapeutics, stands at a pivotal juncture as it seeks to capitalize on the burgeoning market for ...
Alexandria Real Estate Equities (NYSE:ARE) reported its fourth-quarter 2024 earnings, revealing a significant miss in earnings per share (EPS) compared to analyst expectations. The company posted an ...